Patel Sanjiv 4
4 · Relay Therapeutics, Inc. · Filed Dec 18, 2024
Insider Transaction Report
Form 4
Patel Sanjiv
DirectorPresident and CEO
Transactions
- Sale
Common Stock
2024-12-16$5.00/sh−100,000$500,000→ 574,548 total(indirect: By Trust)
Holdings
- 766,130
Common Stock
- 687,355(indirect: By Trust)
Common Stock
Footnotes (4)
- [F1]These shares were sold by the Patel Family Irrevocable Trust of 2019 (the "Trust") pursuant to a Rule 10b5-1 trading plan adopted by the Trust on August 7, 2024.
- [F2]These shares are held in the Trust for the benefit of the reporting person's family members. An independent trustee is trustee of the Trust. The reporting person disclaims beneficial ownership of these securities, and the filing of this report is not an admission that the reporting person is the beneficial owner of these securities for purposes of Section 16 or for any other purpose.
- [F3]Includes 762,360 shares underlying restricted stock units.
- [F4]These shares are held in an irrevocable trust for the benefit of the reporting person's family members. An independent trustee is trustee of the trust. The reporting person disclaims beneficial ownership of these securities, and the filing of this report is not an admission that the reporting person is the beneficial owner of these securities for purposes of Section 16 or for any other purpose.